Challenges in pre-clinical testing of anti-cancer drugs in cell culture and in animal models

Harm HogenEsch, Alexander Yu Nikitin

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Experiments with cultures of human tumor cell lines, xenografts of human tumors into immunodeficient mice, and mouse models of human cancer are important tools in the development and testing of anti-cancer drugs. Tumors are complex structures composed of genetically and phenotypically heterogeneous cancer cells that interact in a reciprocal manner with the stromal microenvironment and the immune system. Modeling the complexity of human cancers in cell culture and in mouse models for preclinical testing is a challenge that has not yet been met although tremendous advances have been made. A combined approach of cell culture and mouse models of human cancer is most likely to predict the efficacy of novel anti-cancer treatments in human clinical trials.

Original languageEnglish (US)
Pages (from-to)183-186
Number of pages4
JournalJournal of Controlled Release
Volume164
Issue number2
DOIs
StatePublished - Dec 10 2012
Externally publishedYes

Fingerprint

Animal Models
Cell Culture Techniques
Pharmaceutical Preparations
Neoplasms
Tumor Cell Line
Heterografts
Immune System
Clinical Trials

Keywords

  • Cancer model
  • Cell culture
  • Mouse
  • Preclinical
  • Xenograft

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Challenges in pre-clinical testing of anti-cancer drugs in cell culture and in animal models. / HogenEsch, Harm; Nikitin, Alexander Yu.

In: Journal of Controlled Release, Vol. 164, No. 2, 10.12.2012, p. 183-186.

Research output: Contribution to journalArticle

@article{2989730653f74b21a5da9980a08cdd8d,
title = "Challenges in pre-clinical testing of anti-cancer drugs in cell culture and in animal models",
abstract = "Experiments with cultures of human tumor cell lines, xenografts of human tumors into immunodeficient mice, and mouse models of human cancer are important tools in the development and testing of anti-cancer drugs. Tumors are complex structures composed of genetically and phenotypically heterogeneous cancer cells that interact in a reciprocal manner with the stromal microenvironment and the immune system. Modeling the complexity of human cancers in cell culture and in mouse models for preclinical testing is a challenge that has not yet been met although tremendous advances have been made. A combined approach of cell culture and mouse models of human cancer is most likely to predict the efficacy of novel anti-cancer treatments in human clinical trials.",
keywords = "Cancer model, Cell culture, Mouse, Preclinical, Xenograft",
author = "Harm HogenEsch and Nikitin, {Alexander Yu}",
year = "2012",
month = "12",
day = "10",
doi = "10.1016/j.jconrel.2012.02.031",
language = "English (US)",
volume = "164",
pages = "183--186",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Challenges in pre-clinical testing of anti-cancer drugs in cell culture and in animal models

AU - HogenEsch, Harm

AU - Nikitin, Alexander Yu

PY - 2012/12/10

Y1 - 2012/12/10

N2 - Experiments with cultures of human tumor cell lines, xenografts of human tumors into immunodeficient mice, and mouse models of human cancer are important tools in the development and testing of anti-cancer drugs. Tumors are complex structures composed of genetically and phenotypically heterogeneous cancer cells that interact in a reciprocal manner with the stromal microenvironment and the immune system. Modeling the complexity of human cancers in cell culture and in mouse models for preclinical testing is a challenge that has not yet been met although tremendous advances have been made. A combined approach of cell culture and mouse models of human cancer is most likely to predict the efficacy of novel anti-cancer treatments in human clinical trials.

AB - Experiments with cultures of human tumor cell lines, xenografts of human tumors into immunodeficient mice, and mouse models of human cancer are important tools in the development and testing of anti-cancer drugs. Tumors are complex structures composed of genetically and phenotypically heterogeneous cancer cells that interact in a reciprocal manner with the stromal microenvironment and the immune system. Modeling the complexity of human cancers in cell culture and in mouse models for preclinical testing is a challenge that has not yet been met although tremendous advances have been made. A combined approach of cell culture and mouse models of human cancer is most likely to predict the efficacy of novel anti-cancer treatments in human clinical trials.

KW - Cancer model

KW - Cell culture

KW - Mouse

KW - Preclinical

KW - Xenograft

UR - http://www.scopus.com/inward/record.url?scp=84869493286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869493286&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2012.02.031

DO - 10.1016/j.jconrel.2012.02.031

M3 - Article

C2 - 22446384

AN - SCOPUS:84869493286

VL - 164

SP - 183

EP - 186

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 2

ER -